Budgetary policies and available actions : a generalization of decision rules for allocation and research decisionsMCKENNA, C; CHALABI, Z; EPSTEIN, D et al.2008, 22 p.Book

Expected Health Benefits of Additional Evidence : Principles, Methods and Applications = Les effets bénéfiques attendues sur la santé des résultats supplémentaires : principes, méthodes et mise en applicationCLAXTON, K; GRIFFIN, S; KOFFIJBERG, H et al.2013, 33 p.Report

Hydrogeologic assessment of exposure to solvent-contaminated drinking water : pregnancy outcomes in relation to exposureWRENSCH, M; SWAN, S; MURPHY, P. J et al.Archives of environmental health. 1990, Vol 45, Num 4, pp 210-216, issn 0003-9896, 7 p.Article

Coverage with evidence development, only in research, risk sharing or patient access scheme ? A framework for coverage decisionWALKER, S; SCULPHER, M; CLAXTON, K et al.2012, 34 p.Report

Dimensions of Design Space : A Decision-theoric Approach to Optimal Research DesignCONTI, S; CLAXTON, K.2008, 20 p.Book

Building a reference case for Bayesian applications to health economics and outcomes researchCLAXTON, K; FENWICK, E; PALMER, S et al.2004, 182 p.Book

Mark versus Luke ? Appropriate methods for the evaluation of public health interventions = Mark contre Luke ? Méthodes appropriées pour l'évaluation des interventions en santé publiqueCLAXTON, K; SCULPHER, M.J; CULYER, A.J et al.2007, 14 p.Book

Decision modelling for health economic evaluation = Modèle de décision pour l'évaluation en économie de la santéBRIGGS, A; CLAXTON, K; SCULPHER, M et al.2006, 237 p.Book

Pregnancy outcomes in women potentially exposed to solvent-contaminated drinking water in San Jose, CaliforniaWRENSCH, M; SWAN, S; LIPSCOMB, J et al.American journal of epidemiology. 1990, Vol 131, Num 2, pp 283-300, issn 0002-9262, 18 p.Article

Methods for the estimation of the NICE cost effectiveness threshold = Méthodes d'estimation du seuil coût/efficacité du NICECLAXTON, K; MARTIN, S; SOARES, M et al.2013, Pagination mult.[126 p.]Report

Value-based pricing for pharmaceuticals : Its role, specification and prospects in a newly devolved NHS = Fixation du prix des médicaments fondée sur la valeur : son rôle, sa spécification et les perspectives au sein d'un nouvel NHS décentraliséCLAXTON, K; SCULPHER, M; CARROLL, S et al.2011, 27 p.Report

An epidemiological study of petroleum refinery employeesWONG, O; MORGAN, R. W; BAILEY, W. J et al.British journal of industrial medicine. 1986, Vol 43, Num 1, pp 6-17, issn 0007-1072Article

Uncertainty, evidence and irrecoverable costs : Informing approval, pricing and research decisions for health technologies = Incertitude, évidence et coûts irrécupérables : fondements pour l'approbation, le financement et les décisions de recherche en matière de technologies de santéCLAXTON, K; PALMER, S; LONGWORTH, L et al.2011, 71 p.Report

The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritisBRAVO VERGEL, Y; HAWKINS, N. S; CLAXTON, K et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 11, pp 1729-1735, issn 1462-0324, 7 p.Article

Defining and characterising structural uncertainty in decision analytic models = Comment est définie et caractérisée l'incertitude structurelle dans les modèles analytiques de décision ?BOJKE, L; CLAXTON, K; PALMER, S et al.2006, 19 p.Book

A pilot study of value of information analysis to support research recommendations for the National Institute for Health and Clinical Excellence = Etude pilote concernant l'analyse de la valeur de l'information selon les recommandations du National Institute for Health and Clinical ExcellenceCLAXTON, K; EGGINGTON, S; GINNELY, L et al.2005, 216 p.Book

Mortality of paint and coatings industry workers: a follow-up studyMORGAN, R. W; CLAXTON, K. W; KAPLAN, S. D et al.Journal of occupational medicine. 1985, Vol 27, Num 5, pp 377-378, issn 0096-1736Article